Author:
Burger David,Back David,Buggisch Peter,Buti Maria,Craxí Antonio,Foster Graham,Klinker Hartwig,Larrey Dominique,Nikitin Igor,Pol Stanislas,Puoti Massimo,Romero-Gómez Manuel,Wedemeyer Heiner,Zeuzem Stefan
Reference29 articles.
1. Fatal lactic acidosis and pancreatitis associated with ribavirin and didanosine therapy;Butt;AIDS Read,2003
2. Poordad F, Lawitz E, Gordon S, Bourlière M, Vierling J, Poynard T, et al. Concomitant medication use in patients with hepatitis C genotype 1 treated with boceprevir combination therapy. In: Sixty second annual meeting of the American Association for the Study of Liver Diseases, San Francisco, California, November 4–8, 2011 [poster 937].
3. EMA. Incivo; Summary of product characteristics. 2012 [cited 2012]; Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002313/WC500115529.pdf.
4. EMA. Victrelis; Summary of product characteristics. 2012 [cited 2012]; Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002332/WC500109786.pdf.
5. Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor;Ghosal;Drug Metab Dispos,2011
Cited by
102 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献